GS-4774

GI-13020 · Gilead Sciences

Drug timelines are a Plus or Pro feature.

3 regulatory and trial events tracked for GS-4774, covering 2014-01-08 to 2019-11-01. Get the full timeline:

Most recent: Clinical Trial Update: Safety and Efficacy of GS-4774 for the Treatment of Chronic Hepatitis B [Phase 2]